SOLVE Chemistry

Investor: XTX Ventures

London-based AI and chemistry startup SOLVE Chemistry has successfully raised £4 million in a Seed funding round. The investment was led by XTX Ventures, with participation from SuperSeed, Creator Fund, climate fund Endgame Capital, and a syndicate of prominent industry angel investors. Summary of transaction details: Value: £4,000,000 (Seed) Sector: DeepTech & AI / ChemTech Advisor: Not disclosed Key Entities: Target: SOLVE Chemistry; Lead Investor: XTX Ventures; Participating Investors: SuperSeed, Creator Fund, Endgame Capital; Key Founders: Dr. Linden Schrecker (CEO), Dr. Jose Pablo Folch Location: London, UK (Scale Space, White City Deep Tech Campus) Note: Spun out from Imperial College London in April 2024 (in a record-breaking timeframe of just one month), SOLVE Chemistry is modernizing chemical R&D. The company operates a "self-driving" lab utilizing novel ultra-high-throughput hardware to collect chemical reaction data 20 times faster than traditional methods. This data trains AI models to predict the most efficient, sustainable, and cost-effective manufacturing routes for pharmaceutical and agrochemical products. Backed by early research sponsored by BASF, the startup will use this capital to quadruple its production capacity and expand its London-based team.